Singapore - English - HSA (Health Sciences Authority)

qianjin - capsule

Canada - English - Health Canada

omni nutraceuticals, inc. - plantago seed - powder - 4.67g - plantago seed 4.67g - herbs and natural products

Australia - English - Department of Health (Therapeutic Goods Administration)

nick jones enterprises pty ltd - zinc sulfate monohydrate, quantity: 15 mg (equivalent: zinc, qty 5.46 mg); serenoa repens, quantity: 250 mg (equivalent: serenoa repens, qty 1000 mg; equivalent: fatty acids, qty 62.5 mg); tribulus terrestris, quantity: 50 mg (equivalent: tribulus terrestris, qty 5 g); epimedium sagittatum, quantity: 25 mg (equivalent: epimedium sagittatum, qty 500 mg); pyridoxine hydrochloride, quantity: 5.25 mg (equivalent: pyridoxine, qty 4.32 mg); magnesium gluconate, quantity: 225 mg (equivalent: magnesium, qty 13.28 mg) - capsule, soft - excipient ingredients: glycerol; purified water; d-alpha-tocopherol; lecithin; iron oxide red; iron oxide black; gelatin; soya oil; titanium dioxide; yellow beeswax; hydrogenated vegetable oil - enhance/promote energy levels ; enhance/promote/physical endurance/capacity/stamina ; aphrodisiac/enhance/improve/promote healthy libido

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

medilica drug store l.l.c canada - 90's plastic bottle - capsule - 250 mg - gastrointestinal system-treatment of bloat

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

medilica drug store l.l.c canada - 60's plastic bottle - tablet - 5 mg - nutrition , blood-oral nutrition

Singapore - English - HSA (Health Sciences Authority)

terumo asia holdings pte ltd - cardiovascular - ultimaster sirolimus eluting coronary stent system is indicated for improving myocardial blood flow in patients with stenotic lesions in coronary arteries, including but not limited to patients with stemi, nstemi, acute coronary syndrome, diabetes mellitus, multivessel disease, bifurcation lesions, patients older than 65 years, male and female patients, patients with totally occluded lesions, long lesions, lesions residing in small coronary vessels, restenotic lesions including in-stent restenosis, ostial lesions, lesions in left main coronary artery. the ultimaster stent system is suitable for both femoral and radial approach.

Singapore - English - HSA (Health Sciences Authority)

terumo asia holdings pte ltd - cardiovascular - ultimaster tansei sirolimus eluting coronary stent system is indicated for improving myocardial blood flow in patients with stenotic lesions in coronary arteries, including but not limited to patients with stemi, nstemi, acute coronary syndrome, diabetes mellitus, multivessel disease, bifurcation lesions, patients older than 65 years, male and female patients, patients with totally occluded lesions, long lesions, lesions residing in small coronary vessels, restenotic lesions including in-stent restenosis, ostial lesions, lesions in left main coronary artery.the ultimaster tansei stent system is suitable for both femoral and radial approach.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

hydrogen peroxide 6% w/v

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ultimate equine ltd - selenium amino acid chelate; chromium amino acid chelate; betacarotene & retinyl palmitate - vitamin-a activity; vitamin d3 = cholecalciferol; dl-alpha-tocopheryl acetate (vitamin e) - oral powder, pre-mix - selenium amino acid chelate chelating agent-mineral active 0.63 mg/do; chromium amino acid chelate chelating agent-mineral active 5.0 mg/do; betacarotene & retinyl palmitate - vitamin-a activity vitamin-a active 6000.0 i.u.; vitamin d3 = cholecalciferol vitamin-d3 active 2000.0 iu/d; dl-alpha-tocopheryl acetate (vitamin e) vitamin-e active 500.0 mg - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

United States - English - NLM (National Library of Medicine)

racinne (hong kong) limited - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - purpose: sun protective lotion indications and usage: after cleansing and toning regimen, apply a small amount onto face and neck area before exposing to outdoor sunlight, avoiding eye area. for optimal results, use after ultimate aqua blanc concentrate for an enhanced brightened complexion.